Flash Forward is a show about possible (and not so possible) future scenarios. What would the warranty on a sex robot look like? How would diplomacy work if we couldn’t lie? Could there ever be a fecal transplant black market? (Complicated, it wouldn’t, and yes, respectively, in case you’re curious.) Hosted and produced by award winning science journalist Rose Eveleth, each episode combines audio drama and journalism to go deep on potential tomorrows, and uncovers what those futures might re ...
…
continue reading
Oncology Data Advisor® and I3 Health에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Oncology Data Advisor® and I3 Health 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!
Player FM 앱으로 오프라인으로 전환하세요!
들어볼 가치가 있는 팟캐스트
스폰서 후원
L
Lipstick on the Rim
![Lipstick on the Rim podcast artwork](https://cdn.player.fm/images/36353102/series/xCZoNvzVfGikvCeg/32.jpg 32w, https://cdn.player.fm/images/36353102/series/xCZoNvzVfGikvCeg/64.jpg 64w, https://cdn.player.fm/images/36353102/series/xCZoNvzVfGikvCeg/128.jpg 128w, https://cdn.player.fm/images/36353102/series/xCZoNvzVfGikvCeg/256.jpg 256w, https://cdn.player.fm/images/36353102/series/xCZoNvzVfGikvCeg/512.jpg 512w)
![Lipstick on the Rim podcast artwork](/static/images/64pixel.png)
1 Amy Schumer & Brianne Howey on the Importance of Female Friendships, Navigating Hollywood's Double Standards, Sharing Their Birth Stories, and MORE 50:05
50:05
나중에 재생
나중에 재생
리스트
좋아요
좋아요50:05![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
This week, in what might be the funniest episode yet, Molly and Emese are joined by co-stars Amy Schumer and Brianne Howey. They get candid about motherhood, career evolution, and their new film, Kinda Pregnant —which unexpectedly led to Amy’s latest health discovery. Amy opens up about how public criticism led her to uncover her Cushing syndrome diagnosis, what it’s like to navigate comedy and Hollywood as a mom, and the importance of sharing birth stories without shame. Brianne shares how becoming a mother has shifted her perspective on work, how Ginny & Georgia ’s Georgia Miller compares to real-life parenting, and the power of female friendships in the industry. We also go behind the scenes of their new Netflix film, Kinda Pregnant —how Molly first got the script, why Amy and Brianne were drawn to the project, and what it means for women today. Plus, they reflect on their early career struggles, the moment they knew they “made it,” and how motherhood has reshaped their ambitions. From career highs to personal challenges, this episode is raw, funny, and packed with insights. Mentioned in the Episode: Kinda Pregnant Ginny & Georgia Meerkat 30 Rock Last Comic Standing Charlie Sheen Roast Inside Amy Schumer Amy Schumer on the Howard Stern Show Trainwreck Life & Beth Expecting Amy 45RPM Clothing Brand A Sony Music Entertainment production. Find more great podcasts from Sony Music Entertainment at sonymusic.com/podcasts and follow us at @sonypodcasts To bring your brand to life in this podcast, email podcastadsales@sonymusic.com Learn more about your ad choices. Visit podcastchoices.com/adchoices…
Oncology Data Advisor
모두 재생(하지 않음)으로 표시
Manage series 1163940
Oncology Data Advisor® and I3 Health에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Oncology Data Advisor® and I3 Health 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.
…
continue reading
414 에피소드
모두 재생(하지 않음)으로 표시
Manage series 1163940
Oncology Data Advisor® and I3 Health에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Oncology Data Advisor® and I3 Health 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.
…
continue reading
414 에피소드
모든 에피소드
×O
Oncology Data Advisor
![Oncology Data Advisor podcast artwork](/static/images/64pixel.png)
1 From Glass Slides to AI: How Digital Pathology and MRD Testing Are Transforming Cancer Care With Osama Khan, MD, and Waqas Haque, MD, MPH 21:50
21:50
나중에 재생
나중에 재생
리스트
좋아요
좋아요21:50![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
In this episode of the Exploring Artificial Intelligence (AI) in Oncology series, Waqas Haque, MD, MPH, Hematology/Oncology Fellow at the University of Chicago, speaks with Osama Khan, MD, Staff Pathologist at Natera, a cell-free DNA (cfDNA) technology company that aims to make personalized genetic testing and diagnostics part of the standard of care. Dr. Khan shares insights into how digital pathology and emerging technologies like AI and measurable residual disease (MRD) testing are revolutionizing oncology, driving precision medicine, and enhancing patient care. Learn more at: https://oncdata.com/digital-pathology-osama-khan…
O
Oncology Data Advisor
![Oncology Data Advisor podcast artwork](/static/images/64pixel.png)
1 Additional Advances in Hemophilia Research and Clinical Trials With Guy Young, MD 11:19
11:19
나중에 재생
나중에 재생
리스트
좋아요
좋아요11:19![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Dr. Guy Young, Director of the Hemostasis and Thrombosis Program, Attending Physician in Hematology-Oncology, and Professor of Pediatrics at Keck School of Medicine at the University of Southern California (USC), is currently serving as co-chair of i3 Health’s CME/NCPD activity, Practice-Changing Advances in the Management of Hemophilia. With new developments in the field occurring over recent months, Dr. Young sat down with us to share recent updates in the hemophilia treatment and management. Click the links below for the full activity! Online accredited CME/NCPD activity: i3health.com/course-information…ment-of-hemophilia Accredited CME/NCPD podcast: i3health.com/course-information…hemophilia-podcast…
O
Oncology Data Advisor
![Oncology Data Advisor podcast artwork](/static/images/64pixel.png)
1 Additional Advances in Hemophilia Research and Clinical Trials With Guy Young, MD 54:33
54:33
나중에 재생
나중에 재생
리스트
좋아요
좋아요54:33![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Dr. Guy Young, Director of the Hemostasis and Thrombosis Program, Attending Physician in Hematology-Oncology, and Professor of Pediatrics at Keck School of Medicine at the University of Southern California (USC), is currently serving as co-chair of i3 Health’s CME/NCPD activity, Practice-Changing Advances in the Management of Hemophilia. With new developments in the field occurring over recent months, Dr. Young sat down with us to share recent updates in the hemophilia treatment and management. Click the links below for the full activity! Online accredited CME/NCPD activity: https://i3health.com/course-information/practice-changing-advances-in-the-management-of-hemophilia Accredited CME/NCPD podcast: https://i3health.com/course-information/practice-changing-advances-in-the-management-of-hemophilia-podcast…
O
Oncology Data Advisor
![Oncology Data Advisor podcast artwork](/static/images/64pixel.png)
1 How AI Is Revolutionizing Precision Oncology With Ian Maurer and Jasmin Hundal, MD, MS, MPH 12:49
12:49
나중에 재생
나중에 재생
리스트
좋아요
좋아요12:49![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
The role of artificial intelligence (AI) and machine learning (ML) in precision oncology has expanded rapidly, offering promising tools for clinicians and researchers to deliver more targeted and efficient care. During the 2024 San Antonio Breast Cancer Symposium (SABCS), Fellows Forum member Dr. Jasmin Hundal conducted an interview with Ian Maurer, Chief Technology Officer at GenomOncology, to explore the applications, challenges, and future directions of AI in oncology. Learn more at: https://oncfellows.com/how-ai-is-revolutionizing-precision-oncology…
O
Oncology Data Advisor
![Oncology Data Advisor podcast artwork](/static/images/64pixel.png)
1 Mendel AI: Enhancing Clinical Data Processing for Empowered Clinical Decision Making With Kristin Maloney, MS, BSN, RN, OCN®, and Waqas Haque, MD, MPH 20:43
20:43
나중에 재생
나중에 재생
리스트
좋아요
좋아요20:43![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Artificial Intelligence (AI) is revolutionizing healthcare, and oncology is no exception. In this episode of the Exploring AI in Oncology series, Kristin Maloney, MS, BSN, RN, OCN®, a Certified Oncology Nurse and the Clinical Informatics Lead at Mendel AI, speaks with Dr. Waqas Haque on how AI can address some of the biggest challenges in oncology. She shares more about Mendel’s innovative platform, which leverages physician-level cognitive capabilities to enhance data process and improve clinical decision making and patient outcomes. Learn more at: https://oncdata.com/mendel-ai-with-kristin-maloney…
O
Oncology Data Advisor
![Oncology Data Advisor podcast artwork](/static/images/64pixel.png)
1 What’s New With HER2: Charting New Paths in NSCLC Care Module 1 Podcast: HER2 in NSCLC: Actionable Insights and Testing Recommendations 15:24
15:24
나중에 재생
나중에 재생
리스트
좋아요
좋아요15:24![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Stay ahead in NSCLC management with this accredited podcast! HER2 alterations, including gene mutations and protein overexpression, are key therapeutic targets, but their complexity can challenge treatment decisions. In Module 1 of this podcast, Dr. Julia Kathleen Rotow, Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School, provides essential insights and testing recommendations to optimize patient care. Listen now! Click here to claim CME/NCPD credit: https://bit.ly/49NCaQu…
O
Oncology Data Advisor
![Oncology Data Advisor podcast artwork](/static/images/64pixel.png)
1 What’s New With HER2: Charting New Paths in NSCLC Care Module 2 Podcast 18:34
18:34
나중에 재생
나중에 재생
리스트
좋아요
좋아요18:34![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Stay ahead in NSCLC management with our accredited podccast! HER2 alterations, including gene amplifications, mutations, and protein overexpression, are critical therapeutic targets, but their heterogeneity can complicate treatment strategies. In Module 2, Dr. Julia Kathleen Rotow, Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School, explores advanced testing methodologies and strategies to navigate HER2 complexities and optimize patient outcomes. Listen now! Click here to claim CME/NCPD credit: https://bit.ly/405xEJO…
O
Oncology Data Advisor
![Oncology Data Advisor podcast artwork](/static/images/64pixel.png)
1 Ontada, Microsoft, and Azure AI: Collaborating to Transform Real-Word Data Processing in Oncology 18:33
18:33
나중에 재생
나중에 재생
리스트
좋아요
좋아요18:33![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
In this episode of Exploring Artificial Intelligence in Oncology, Wanmei Ou, PhD, the Vice President of Product, Clinical Decision Support, & Analytics Data Platform at Ontada, shares more about Ontada’s collaboration with Microsoft to transform unstructured oncology data with Azure OpenAI technology. Her discussion with Dr. Waqas Haque highlights how AI is transforming clinical workflows, reducing documentation burdens, and driving improved patient outcomes. Learn more at: https://oncdata.com/ontada-microsoft-azure-ai-real-world-data-processing-in-oncology/…
O
Oncology Data Advisor
![Oncology Data Advisor podcast artwork](/static/images/64pixel.png)
1 Zanidatamab: A New Frontier in Treating HER2-Positive Biliary Tract Cancer With James Harding, MD 17:26
17:26
나중에 재생
나중에 재생
리스트
좋아요
좋아요17:26![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
The FDA's recent accelerated approval of zanidatamab marks a significant breakthrough in the treatment landscape for human epidermal growth factor receptor 2 (HER2)–positive biliary tract cancer (BTC). Following the approval, Dr. James Harding, Associate Attending Physician in the Gastrointestinal Oncology and Early Drug Development Services at Memorial Sloan Kettering Cancer Center, sat down to provide oncology clinicians with insights into its significance and implications for clinical practice. Learn more at: https://oncdata.com/zanidatamab-biliary-tract-cancer-james-harding/…
O
Oncology Data Advisor
![Oncology Data Advisor podcast artwork](/static/images/64pixel.png)
As Lung Cancer Awareness Month progresses, this discussion hosted by Oncology Data Advisor sheds light on the advancements in lung cancer therapies, unmet needs, the evolving landscape of molecular testing, and actionable insights for clinicians.
O
Oncology Data Advisor
![Oncology Data Advisor podcast artwork](/static/images/64pixel.png)
1 Diagnosis and Management of Dedifferentiated Liposarcoma: A Multidisciplinary Task Force Podcast 28:57
28:57
나중에 재생
나중에 재생
리스트
좋아요
좋아요28:57![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Gain valuable insights into the complexities of diagnosing and managing dedifferentiated liposarcoma (DDLPS) and earn free CME credit with our latest podcast. This episode features expert guidance from Dr. Richard F. Riedel of Duke University and Dr. Candace L. Haddox of Dana-Farber Cancer Institute. Delve into the latest on identifying MDM2 and CDK4 amplification, challenges in diagnosing DDLPS, and updates on emerging therapies like CDK4/6 inhibitors and immunotherapies. Learn how a multidisciplinary approach enhances patient outcomes in this rare and aggressive soft tissue sarcoma. Listen now and advance your expertise! Click here to claim your CME credit: i3health.com/course-information/podcast-ddlps…
O
Oncology Data Advisor
![Oncology Data Advisor podcast artwork](/static/images/64pixel.png)
1 Clinic Conversation of the Week: How to Talk to Patients About the BENEFIT Trial in Multiple Myeloma 5:36
5:36
나중에 재생
나중에 재생
리스트
좋아요
좋아요5:36![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
The BENEFIT trial, which studied isatuximab, lenalidomide, dexamethasone, and bortezomib in transplant-ineligible multiple myeloma, was published earlier this year in Nature Medicine. I'll be talking about this as if it was one of my patients coming to me with a copy of this paper in their hand that a friend or loved one forwarded to them. What do I tell them?…
O
Oncology Data Advisor
![Oncology Data Advisor podcast artwork](/static/images/64pixel.png)
1 Artera: Personalizing Treatment Decisions in Prostate Cancer and Beyond With Waqas Haque, MD, MPH, and Trevor Royce, MD, MS, MPH, FASCO 15:04
15:04
나중에 재생
나중에 재생
리스트
좋아요
좋아요15:04![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Artera: Personalizing Treatment Decisions in Prostate Cancer and Beyond With Waqas Haque, MD, MPH, and Trevor Royce, MD, MS, MPH, FASCO by i3 Health
O
Oncology Data Advisor
![Oncology Data Advisor podcast artwork](/static/images/64pixel.png)
1 Exclusive Sneak Peek: Unlocking What's Next in Genetic Counseling and Cancer Care! 9:30
9:30
나중에 재생
나중에 재생
리스트
좋아요
좋아요9:30![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
i3 Health is pleased to invite you to Pathways to Precision: Integrating Genetic Counseling and Testing Into Cancer Care, a free, live webinar held on November 7 at 10:00 am Eastern and November 19 at 11:30 am Eastern. This interview features an exclusive preview from the two webinar co-chairs, Dr. Filipa Lynce, Director of the Inflammatory Breast Center at Dana-Farber Cancer Center and Assistant Professor of Medicine at Harvard Medical School, and Catherine Skefos, Certified Genetic Counselor in the Clinical Cancer Genetics Program at the University of Texas MD Anderson Cancer Center. Click below to register for this insightful webinar and enhance your understanding of genetic testing and counseling in cancer care! Register for the webinar: https://i3health.com/course-information/pathways-to-precision-integrating-genetic-counseling-and-testing-into-cancer-care…
O
Oncology Data Advisor
![Oncology Data Advisor podcast artwork](/static/images/64pixel.png)
1 Revolutionizing Cancer Diagnostics Through AI-Powered Analysis: CorePath 15:04
15:04
나중에 재생
나중에 재생
리스트
좋아요
좋아요15:04![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
In this episode of Exploring Artificial Intelligence in Oncology, Dr. Waqas Haque, MD, sits down with Aamir Ehsan, MD, the Founder and CEO of CorePath Laboratories in San Antonio, Texas. Together they discuss how CorePath utilizes AI in pathology.
플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.